A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy

From this preliminary safety study, it appears that QR-333 may safely offer relief of symptoms of diabetic neuropathy and improve quality of life. These findings warrant further investigation of this topical compound.